Mindy Wan

Dr. Mindy Wan is a Director for Technology Development at KBI Biopharma. She has obtained her Ph.D in Biochemistry from University Zurich, Switzerland, in 1992. Over the past 26 years she has focused on bio-pharmaceutical industry and specializes in biologics processes and characterization. She is currently leading an effort for an improved HCP detection strategy at KBI. Prior to join KBI, she held various leadership positions for process development and manufacturing sciences at AstraZeneca, AbbVie, and Covance Biotech.

Education

• Ph.D. University of Zurich (1988 — 1992)

Companies

• Director Business Development KBI Biopharma (2016)
• Director, Downstream Processes, MS&T MedImmune (A Subsidiary of AstraZeneca LLC) (2009 — 2016)
• Sr. Group leader Abbott Laboratories (2003 — 2009)
• Staff Scientist/Project Technical Manager Diosynth RTP (former Covance Biotechnoloty Inc.) (1998 — 2003)
• Process Development Scientist Tanox Biosystems, Inc. (1995 — 1998)
• Associate Professor National University of Singapore (1992 — 1995)
• Graduate student/Research Associate Shanghai Institution of Pharmaceutical Industry (1982 — 1987)

Skills

The most important

• Protein Purification
• Chromatography
• Validation

Other

Management, Start-ups, Manufacturing, Leadership, Technology Transfer, Pharmaceutical Industry, GMP, Purification, Biotechnology, Biopharmaceuticals